publication date: Feb. 3, 2017

Funding Opportunities SU2C to fund Dream Teams focused on “cancer interception” in pancreas and lungs

Stand Up To Cancer broke new ground today when the American Association for Cancer Research, its scientific partner, announced to the cancer research community funding to support new Dream Teams focused on “cancer interception” of the pancreas and lungs.

Stand Up To Cancer is joined by collaborators the Lustgarten Foundation for Pancreatic Cancer Research, and by LUNGevity Foundation and the American Lung Association’s LUNG FORCE, in supporting these two Interception Dream Teams of the pancreas and lungs, respectively.

“Interception is the new frontier in cancer research,” said Phillip Sharp, chairperson of the SU2C Scientific Advisory Committee, Institute Professor at the Massachusetts Institute of Technology and its Koch Institute for Integrative Cancer Research, and winner of the 1993 Nobel Prize in Physiology or Medicine. “Essentially, we want to find cancer at its very earliest stages and stop it before it becomes a problem for the patient. This approach has not been a focus of any of the previous Dream Teams and could greatly benefit patients.”

“Cancer interception is the active way of combating cancer and carcinogenesis at earlier and earlier stages,” said Elizabeth Blackburn, president of the Salk Institute for Biological Studies, winner of the 2009 Nobel Prize in Physiology or Medicine, and … Continue reading SU2C to fund Dream Teams focused on “cancer interception” in pancreas and lungs

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.